Autoimmune Lymphoproliferative Syndrome
📧 Sign up to get email alerts when something new happens for Autoimmune Lymphoproliferative Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies [Phase 2]
This update describes a Phase 2 pilot trial evaluating allogeneic blood or marrow transplantation for primary immunodeficiency disorders, wi…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients [Phase 2]
A Phase 2 clinical trial evaluating the ITK inhibitor soquelitinib to reduce lymphoproliferation and improve cytopenias in Autoimmune Lympho…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
A National Institute of Allergy and Infectious Diseases-sponsored study of autoimmune lymphoproliferative syndrome (ALPS) is currently recru…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation [Phase 2]
A Phase 2 study evaluating allogeneic hematopoietic cell transplantation for disorders of T-cell proliferation and/or dysregulation, sponsor…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Immune Disorder HSCT Protocol [Phase 2]
Phase 2 clinical trial update on a hematopoietic stem cell transplant protocol for several inherited immune deficiency disorders; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition [Phase 2]
Phase 2 clinical trial investigating treatment of inflammation before stem cell transplant in people with Primary Immune Regulatory Disorder…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity [Phase 2]
A Phase 2 clinical trial exploring allogeneic hematopoietic stem cell transplantation for patients with inborn errors of immunity is current…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
A recruiting clinical trial in France aims to develop a diagnosis, prognosis, and therapeutic decision-support tool for autoimmune and infla…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
A completed clinical trial evaluating fluorodeoxyglucose-positron emission tomography (FDG-PET) for evaluating autoimmune lymphoproliferativ…
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Sirolimus for Autoimmune Disease of Blood Cells [Phase 1, Phase 2]
A phase 1/2 trial evaluating sirolimus for autoimmune blood cell disorders, including autoimmune pancytopenia and ALPS; the study is complet…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS) [Phase 1, Phase 2]
A Phase 1/2 trial evaluated valproic acid (Depakote) for autoimmune lymphoproliferative syndrome (ALPS); the study has completed and results…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome [Phase 1]
Phase 1 trial of pyrimethamine for autoimmune lymphoproliferative syndrome has completed, sponsored by the National Institute of Allergy and…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome [Phase 1]
Phase 1 trial evaluating a pyrimethamine and sulfadoxine combination for autoimmune lymphoproliferative syndrome has completed, sponsored by…